Use of a New Medicine "Daratumumab" to Treat Left-over Cancer in a Blood Cancer Called "T Acute Lymphoblastic Leukemia"
Clinical trial NCT07021677 · RECRUITING
Trial details
- NCT number
- NCT07021677
- Sponsor
- Tata Memorial Centre
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-08-28
- Primary completion
- 2026-08-28
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.